Mankind Pharma Ltd

Mankind Pharma Ltd

Mankind Pharma Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015. The company has also issued a corporate guarantee in favour of Bharat Serums and Vaccines Limited and disclosed related party transactions.

Mankind Pharma Ltd

Mankind Pharma Ltd reported Q1FY27 financial results with revenue growth of 12.9% YoY, EBITDA growth of 24.7% YoY, and PAT growth of 29.1% YoY. The company's domestic business (ex-CH) grew by 11.0% led by double-digit growth in Mankind domestic business, while OTC segment grew by ~4% and International business grew 29% YoY.

Mankind Pharma Ltd

Mankind Pharma Ltd has announced its Q1FY27 investor presentation, showcasing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 10.5% YoY and exports business growing 29% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA. The presentation highlights the company's steady growth trajectory, expansion in specialty and super specialty segments, and strong performance in key focused brands.

Mankind Pharma Ltd

Mankind Pharma Ltd's board of directors has approved the issuance of a corporate guarantee in favor of Bharat Serums & Vaccines Limited, a wholly-owned subsidiary, and has also considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Mankind Pharma Ltd

Mankind Pharma Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the issuance of a corporate guarantee in favor of its wholly-owned subsidiary Bharat Serums and Vaccines Limited.

Mankind Pharma Ltd

Mankind Pharma Ltd's board meeting outcome announced financial results for Q1 2026, with corporate guarantee issued in favour of Bharat Serums and Vaccines Ltd, and unaudited standalone financial results reviewed by S.R. Batliboi & Co. LLP and Bhagi Bhardwaj Gaur & Co.

Mankind Pharma Ltd

Mankind Pharma Ltd has completed the sale of its 100% stake in Broadway Hospitality Services Private Limited for ₹ 49 Crore, with the transaction now closed.